Pichia-derived human CYPs
Streamline your toxicity screening, metabolite synthesis or late-stage functionalization with our Human CYP Panel
Human CYP Panel
Boost your MedChem work with our Human CYP Panel. Aminoverse offers a curated selection of 8 major human cytochrome P450 enzymes CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2E1, CYP2D6, and CYP3A enabling efficient assessment of metabolic degradation products in toxicity screens, synthesis of specific compounds or drug discovery programs.
- Human CYPs for industrial application
- Available from mg to kg scale
- CASE STUDIES
Proven Product Performance & Innovation
🧪 PROCESS CHEMISTRY
Transforming Chemical Manufacturing Through Intelligent Biocatalysis
Aminoverse collaborated with a chemical manufacturing organization to...
🌿 NOVEL PATHWAYS
Designing Novel Enzymatic Pathways for Sustainable Production
Aminoverse partnered with a sustainability-focused organization to...
🧬 NEW PRODUCT CATEGORY
Creating Entirely New Product Categories Through Enzyme Innovation
Aminoverse supported a product development initiative aimed...
💊 DRUG DISCOVERY
Accelerating Drug Discovery with Advanced Customized Enzyme Platforms
Aminoverse partnered with a pharmaceutical research organization...
⚙️ SUPERIOR PERFORMANCE
Engineering High-Performance Enzymes for Industrial Applications
Aminoverse collaborated with an industrial partner to enhance...
WHY CYP ENZYMES?
Cytochrome P450 monooxygenases (CYPs) are a heme-containing superfamily of enzymes that catalyze the activation of molecular oxygen to perform mixed-function oxidations. Relying on NAD(P)H for electron regeneration, these biocatalysts facilitate complex transformations - including C-hydroxylation, N-, O-, and S-dealkylation, and epoxidation - on diverse substrates such as xenobiotics, steroids, and fatty acids. Their ability to functionalize non-activated C-H bonds provides a precise alternative to traditional chemical oxidation, which often lacks the regioselectivity required for complex molecular scaffolds.
WHY OUR CYPs ARE BETTER?
Typically produced in E. coli in low quantities, our CYPs are recombinantly expressed in specialized Komagataella phaffii (Pichia pastoris) strains. Supplied as whole-cell biocatalyst, Pichia-derived CYPs achieve higher performance at lower material input.
The Human CYP Panel delivers 8 major human isoforms (1A1, 1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4) in a ready-to-screen format.
Ideally suited for toxicity screens, metabolite synthesis and late-stage derivatization, the CYP platform is mechanistically complementary to our UPOs and KGOs, extending the accessible product scope.
Any CYP can be scaled to kilogram quantities to give way for both scaled reaction and high through-put processes.
- SCALE-UP READY
From mg screening to kg enzyme powder supply
Start with milligram-level enzyme tests, then move to kilogram powder quantities for pilot and production runs. Curated panels, reliable supply, and scale-ready delivery - all from one partner.
- our enzyme ProductS
Check out our other enzyme products
CYPs are essential to pharmaceutical applications
When you are tired of the poor performance of commercially available CYPs, our Pichia-derived human CYPs are worth a look. Reach out to Rainer for a call.